Publications of A. Schuld
All genres
Journal Article (63)
2012
Journal Article
135 (1-3), pp. 123 - 127 (2012)
Sleep propensity at daytime as assessed by Multiple Sleep Latency Tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine. Schizophrenia Research
Journal Article
35 (2), pp. 231 - 236 (2012)
Glucose Tolerance in Patients with Narcolepsy. Sleep
Journal Article
27 (Suppl. 1), 0-27 (2012)
Sleep propensity at daytime as assessed by multiple sleep latency tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine. European Psychiatry 2011
Journal Article
45 (9), pp. 1223 - 1228 (2011)
The stress hormone system in various sleep disorders. Journal of Psychiatric Research 2009
Journal Article
34 (1), pp. 118 - 128 (2009)
Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. Psychoneuroendocrinology 2007
Journal Article
27 (6), pp. 662 - 666 (2007)
Clozapine and olanzapine are associated with food craving and binge eating - Results from a randomized double-blind study. Journal of Clinical Psychopharmacology
Journal Article
40 (5), p. 241 - 241 (2007)
Daytime sleep after glucose intake in patients with narcolepsy. Pharmacopsychiatry
Journal Article
2, pp. 293 - 302 (2007)
Immunoendocrine abnormalities in narcolepsy. Sleep Medicine Clinics 2006
Journal Article
60, pp. 882 - 888 (2006)
Successful antidepressant therapy restores the disturbed interplay between TNF-α system and HPA axis. Biological Psychiatry
Journal Article
29 (1), p. 170 - 170 (2006)
Changes in weight and glucose tolerance during treatment with mirtazapine. Diabetes Care
Journal Article
114, pp. 322 - 328 (2006)
Low doses of dexamethasone affect immune parameters in the absence of immunological stimulation. Experimental and Clinical Endocrinology & Diabetes 2005
Journal Article
38 (5), p. 230 - 230 (2005)
Impaired glucose tolerance in patients with narcolepsy. Pharmacopsychiatry
Journal Article
38 (5), p. 249 - 249 (2005)
Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis. Pharmacopsychiatry
Journal Article
38 (5), pp. 248 - 249 (2005)
Does antidepressant therapy improve glucose metabolism? Pharmacopsychiatry
Journal Article
38 (5), p. 264 - 264 (2005)
Efficacy of electroconvulsive therapy for depressive disorders in a Bavarian district hospital. Pharmacopsychiatry
Journal Article
38 (5), p. 270 - 270 (2005)
Cognitive-behavioral therapy of patients with pure and comorbid panic disorder in a hospital setting - a comparison of therapy response. Pharmacopsychiatry
Journal Article
38 (5), p. 270 - 270 (2005)
Metabolic abnormalities in patients with chronic psychiatric disorders receiving long-term psychopharmacological treatment. Pharmacopsychiatry
Journal Article
102 (31-32), pp. A 2172 - A 2177 (2005)
Gewichtszunahme unter Psychopharmakotherapie. Deutsches Ärzteblatt
Journal Article
39, pp. 35 - 42 (2005)
Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain. Journal of Psychiatric Research
Journal Article
179 (2), pp. 447 - 451 (2005)
Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium. Psychopharmacology